VytlOne and Maury Regional Health Expand Their Pharmacy Services Partnership
VytlOne, a leading provider of pharmacy solutions, is expanding its existing partnership with Maury Regional Health—a 255-bed, not-for-profit, vertically integrated […]
Blog, Maxor
The rise of long-acting injectable drugs: Changing the way we manage chronic disease
Exploring the benefits and challenges of LAIs in modern medicine Overview In the ever-evolving world of healthcare, long-acting injectable drugs
GLP-1 Trends
GLP-1 agonists have become increasingly popular as a treatment option for type 2 diabetes and obesity. These medications continue to
Biosimilar Trends
Biosimilars represent both a significant opportunity and challenge for the biopharmaceutical industry. Download our trend report to learn more about
Cell and Gene Therapy
As the field of cell and gene therapy advances, new opportunities will emerge for healthcare stakeholders, including payers, providers, and
Maxor Specialty Pharmacy receives Rare and Orphan Pharmacy Designation
Maxor Specialty Pharmacy, a division of Maxor National Pharmacy Services (Maxor), is proud to announce that they have been granted
Preparing Children with Chronic Conditions for the School Year
The beginning of the school year is an exciting time for families, but having a child with a chronic condition
Enhanced Clinical Reporting Solutions
The Maxor Specialty Enhanced Clinical Reporting Solutions Platform is built to support enhanced patient-level reporting on clinical interventions and patient-reported
Savings Calculator
Curious about your savings potential? Use our ROI Calculator to see how VytlOne can lower costs and boost outcomes for
340B Resource Guide
With the right tools, partners, and insights, your health system can maximize 340B savings and reinvest them to advance patient